参考文献/References:
[1] 赵耕.2型糖尿病患者血清网膜素-1水平与肾损伤程度关系的研究[J].现代检验医学杂志, 2018, 33(1): 115-117. ZHAO Geng. Study on the relationship between serum omentin-1 level and degree of kidney injuryin patient with type 2 diabetic nephropathy[J].Journal of Modern Laboratory Medicine,2018,33(1):115-117.
[2] AL-RUBEAAN K,SIDDIQUI K, AL-GHONAIM M A, et al. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.[J]. Scientific Reports, 2017, 7(1):2684.
[3] MAFI A, AGHADAVOD E, MIRHOSSEINI N, et al. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression[J]. Journal of Cellular Physiology, 2018, 234(1): 42-50.
[4] 张宁, 张银辉, 吴正林, 等.尿蛋白电泳评估肾损伤临床价值的探讨[J].现代检验医学杂志, 2018, 33(5): 64- 69. ZHANG Ning,ZHANG Yinhui,WU Zhenglin,et al. Study on clinical value of urinary protein electrophoresis of assessing renal injury[J]. Journal of Modern Laboratory Medicine, 2018, 33(5):64-69.
[5] CAO Jing , MURAT C , AN Weijun , et al. Human umbilical tissue-derived cells rescue retinal pigment epithelium dysfunction in retinal degeneration[J]. Stem Cells (Dayton, Ohio), 2016, 34(2): 367-379.
[6] WOLF G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology[J]. European Journal of Clinical Investigation, 2004, 34(12): 785-796.
[7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华内分泌代谢杂志, 2014, 30(10): 893-942. Chinese Diabetes Society. Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus (2013 Edition)[J].Chinese Journal of Endocrinology and Metabolism,2014,30(10):893-942.
[8] 杜姝姗, 周婷婷, 郭常辉.二肽基肽酶-4抑制剂利格列汀治疗对2型糖尿病患者血清色素上皮细胞衍生因子水平的影响[J].中华内分泌代谢杂志, 2015, 31(8): 696-699. DU Shushan,ZHOU Tingting,GUO Changhui. Effect of dipeptidyl peptidase-4 inhibitors linagliptin on the expression of serum pigment epithelium-derived factor in type 2 diabetes patients [J].Chinese Journal of Endocrinology and Metabolism, 2015, 31(8):696-699.
[9] DELANAYE P, CAVALIER E, KRZESINSKI J M. Estimated glomerular filtration rate[J]. Annals of Internal Medicine, 2007, 146(1): 74-75.
[10] JEDRYCHOWSKI M P, WRANN C D, PAULO J A, et al. Detection and quantitation of circulating human Irisin by tandem mass spectrometry[J]. Cell Metabolism, 2015, 22(4): 734-740.
[11] TIANO J P, SPRINGER D A, RANE S G. SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during exercise[J]. The Journal of Biological Chemistry, 2015, 290(18): 11431.
[12] LIU Tongyan, SHI Changxiang, GAO Run, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes[J]. Clinical Science (London, England : 1979), 2015, 129(10): 839-850.
[13] HU Wenchao, WANG Rui, LI Jun, et al. Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy[J]. Annals of Clinical Biochemistry, 2016, 53(Pt 1): 67-74.
[14] 苏洋, 梅秋雁.血浆NGAL, Cys C和尿NAG/Crea联合检测对早期糖尿病肾病诊断价值的研究[J].现代检验医学杂志, 2018, 33(1): 99-101, 105. SU Yang, MEI Qiuyan. Study on combined determination plasma NGAL,cys C and urinary NAG/Crea for the diagnosis of early diabetic nephropathy [J]. Journal of Modern Laboratory Medicine,2018, 33(1):99-101,105.
[15] LI Dongjie, HUANG Fang, LU Wenjie, et al. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation[J]. Acta Physiologica (Oxford, England), 2015, 213(3): 711-721.
[16] OLTEAN S, QIU Yan, FERGUSON J K, et al. Vascular endothelial growth Factor-A(165)b is protective and restores endothelial glycocalyx in diabetic nephropathy[J]. Journal of the American Society of Nephrology, 2015, 26(8): 1889-1904.
[17] 肖艳新, 王翯, 李立琴, 等.糖尿病肾病患者血清血管内皮生长因子和色素上皮衍生因子水平变化[J].微循环学杂志, 2015, 25(3): 30-33. XIAO Yanxin,WANG He,LI Liqin,et al. Change and significance of serum vascular endothelial growth factor and pigment epithelium-de-rived factor in type 2 diabetic nephropathy [J] .Chinese Journal of Microcirculation,2015,25(3):30-33.
[18] 张丽, 乔晞.烟酰胺腺嘌呤二核苷酸磷酸氧化酶与肾间质纤维化[J].中华肾病研究电子杂志, 2018, 7(1): 44-46. ZHANG Li,QIAO Xi.NADPH oxidase and renal interstitial fibrosis[J].Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2018,7(1):44-46.
[19] CHEUNG C Y Y, LEE C H, TANG C S, et al. Genetic regulation of pigment epithelium-derived factor(PEDF):an exome-chip association analysis in Chinese subjects with type 2 diabetes[J]. Diabetes, 2019, 68(1): 198-206.